Abingdon Health Plc
ABDXF · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $16,746 | $16,759 | $16,765 | $4,858 |
| - Cash | $1,440 | $3,236 | $2,397 | $4,977 |
| + Debt | $1,049 | $1,019 | $1,280 | $1,495 |
| Enterprise Value | $16,355 | $14,542 | $15,648 | $1,376 |
| Revenue | $6,135 | $4,045 | $2,835 | $11,618 |
| % Growth | 51.7% | 42.7% | -75.6% | – |
| Gross Profit | $3,679 | $2,075 | -$5,229 | $3,394 |
| % Margin | 60% | 51.3% | -184.4% | 29.2% |
| EBITDA | -$916 | -$3,173 | -$19,887 | -$4,771 |
| % Margin | -14.9% | -78.4% | -701.5% | -41.1% |
| Net Income | -$1,271 | -$3,469 | -$21,262 | -$6,973 |
| % Margin | -20.7% | -85.8% | -750% | -60% |
| EPS Diluted | -0.004 | -0.011 | -0.073 | -0.073 |
| % Growth | 63.2% | 84.4% | -0.4% | – |
| Operating Cash Flow | -$1,659 | $1,002 | -$7,735 | -$12,876 |
| Capital Expenditures | -$41 | -$157 | -$760 | -$7,251 |
| Free Cash Flow | -$1,700 | $845 | -$8,495 | -$20,127 |